Literature DB >> 20063164

Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction.

Thomas R W Herrmann1, T Bach, F Imkamp, A Georgiou, M Burchardt, M Oelke, A J Gross.   

Abstract

BACKGROUND: Transurethral removal of prostatic tissue is the treatment choice for benign prostatic enlargement and benign prostatic obstruction. Urodynamic results are directly linked to the amount of removed tissue which, however, is directly associated with intra- and postoperative morbidity. Transurethral laser operations of the prostate offer the advantage of decreased bleeding complications and the possibility to treat patients with bleeding disorders or anticoagulative treatment. The aim of the article is to present a novel technique of complete transurethral removal of the transition zone (enucleation) with the support of the Thulium laser to combine complete anatomical enucleation and maximum urodynamic efficacy with minimal side-effects.
MATERIALS AND METHODS: We present five distinct surgical steps for transurethral complete removal of the transition zone of the prostate (Thulium laser enucleation of the prostate, ThuLEP). Surgical steps are presented in chronological order with the help of intraoperative pictures. Laser energy of 70-90 W is only used for the incision at the verumontanum and bladder neck for removal of the middle lobe, whereas laser energy of 30 W was only used for coagulation of small vessel crossing the surgical capsule towards the transition zone and bladder neck for dissection of the lateral lobes. The lobes themselves are liberated by blunt dissection.
CONCLUSIONS: ThuLEP offers complete removal of the transition zone no matter what prostatic size. The techniques combine maximum efficacy with minimal side-effects. Clinical results comparing ThuLEP with open prostatectomy or transurethral resection are awaited.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063164     DOI: 10.1007/s00345-009-0503-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  28 in total

1.  Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate.

Authors:  Gunnar Wendt-Nordahl; Stephanie Huckele; Patrick Honeck; Peter Alken; Thomas Knoll; Maurice Stephan Michel; Axel Häcker
Journal:  J Endourol       Date:  2008-05       Impact factor: 2.942

2.  Transurethral enucleation of benign prostatic hyperplasia.

Authors:  Y Hiraoka; M Akimoto
Journal:  J Urol       Date:  1989-11       Impact factor: 7.450

3.  Clinical implications of the rise and fall of prostate specific antigen after laser prostatectomy.

Authors:  M P van Iersel; C M Thomas; W P Witjes; R de Graaf; J J de la Rosette; F M Debruyne
Journal:  Br J Urol       Date:  1996-11

4.  Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?

Authors:  William W Tinmouth; Enmar Habib; Samuel C Kim; Ramsay L Kuo; Ryan F Paterson; Colin L Terry; Mostafa Elhilali; James E Lingeman
Journal:  J Endourol       Date:  2005-06       Impact factor: 2.942

5.  Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.

Authors:  Hazem M Elmansy; Ehab A Elzayat; John S Sampalis; Mostafa M Elhilali
Journal:  Urology       Date:  2009-09-20       Impact factor: 2.649

6.  [Thulium:YAG vaporesection of the prostate. First results].

Authors:  T Bach; T R W Herrmann; R Ganzer; A Blana; M Burchardt; A J Gross
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

7.  A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).

Authors:  A H H Tan; P J Gilling; K M Kennett; C Frampton; A M Westenberg; M R Fraundorfer
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

8.  Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.

Authors:  Alexis E Te; Terrence R Malloy; Barry S Stein; James C Ulchaker; Unyime O Nseyo; Mahmood A Hai; Reza S Malek
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

9.  Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.

Authors:  Moritz F Hamann; Carsten M Naumann; Christof Seif; Christof van der Horst; Klaus-Peter Jünemann; Peter M Braun
Journal:  Eur Urol       Date:  2008-05-16       Impact factor: 20.096

10.  Reference range of prostate-specific antigen after transurethral resection of the prostate.

Authors:  G Aus; S Bergdahl; R Frösing; P Lodding; E Pileblad; J Hugosson
Journal:  Urology       Date:  1996-04       Impact factor: 2.649

View more
  55 in total

Review 1.  New advances in benign prostatic hyperplasia: laser therapy.

Authors:  Jessica Mandeville; Ehud Gnessin; James E Lingeman
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

2.  Efficacy and safety of prostate vaporesection using a 120-W 2-μm continuous-wave Tm:YAG laser (RevoLix 2) in patients on continuous oral anticoagulant or antiplatelet therapy.

Authors:  Luciano Macchione; Giuseppe Mucciardi; Alessandro Gali'; Antonina Di Benedetto; Salvatore Butticè; Carlo Magno
Journal:  Int Urol Nephrol       Date:  2013-07-27       Impact factor: 2.370

Review 3.  Thulium: YAG 2 mum cw laser prostatectomy: where do we stand?

Authors:  T Bach; S J Xia; Y Yang; S Mattioli; G M Watson; A J Gross; T R W Herrmann
Journal:  World J Urol       Date:  2010-03-05       Impact factor: 4.226

4.  Laparoscopic adenomectomy versus Eraser laser enucleation of the prostate.

Authors:  L Lusuardi; S Hruby; G Janetschek; M Mitterberger; M Sieberer; D Colleselli; T Kunit; W Hitzl; B Kloss
Journal:  World J Urol       Date:  2015-01-03       Impact factor: 4.226

5.  Update on lasers in urology 2015.

Authors:  Thomas R W Herrmann; Thorsten Bach
Journal:  World J Urol       Date:  2015-04       Impact factor: 4.226

6.  En bloc and two-lobe techniques for laser endoscopic enucleation of the prostate: retrospective comparative analysis of peri- and postoperative outcomes.

Authors:  Dmitry Enikeev; Mark Taratkin; Ekaterina Laukhtina; Tatyana Alekseeva; Olesya Snurnitsyna; Natalya Potoldykova; Andrey Gerasimov; Petr Glybochko
Journal:  Int Urol Nephrol       Date:  2019-08-20       Impact factor: 2.370

Review 7.  Nomenclature in thulium laser treatment of benign prostatic hyperplasia: it's time to pull the rabbit out of the hat.

Authors:  Serena Maruccia; Irene Fulgheri; Emanuele Montanari; Stefano Casellato; Luca Boeri
Journal:  Lasers Med Sci       Date:  2021-01-03       Impact factor: 3.161

Review 8.  Thulium (Tm:YAG) laser vaporesection of prostate and bipolar transurethral resection of prostate in patients with benign prostate hyperplasia: a systematic review and meta-analysis.

Authors:  Yu Lan; Wenqi Wu; Luhao Liu; Shiyu Zhou; Chuangxin Lan; Irene Raphael Ketegwe; Guohua Zeng
Journal:  Lasers Med Sci       Date:  2018-06-27       Impact factor: 3.161

9.  Natural orifice (NOTES) transurethral sutureless radical prostatectomy with thulium laser support: first patient report.

Authors:  Udo Nagele; Aristotelis G Anastasiadis; Ute Walcher; Andre P Nicklas; Axel S Merseburger; Thomas R W Herrmann
Journal:  World J Urol       Date:  2011-07-08       Impact factor: 4.226

10.  Reasons to go for thulium-based anatomical endoscopic enucleation of the prostate.

Authors:  B Becker; C Netsch; G Bozzini; T R W Herrmann; T Bach; D Enikeev; A J Gross
Journal:  World J Urol       Date:  2021-05-04       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.